Skip to main content
Article
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene
Molecular Therapy (2004)
  • Tulin Budak-Alpdogan, University of Medicine and Dentistry of New Jersey
  • Onder Alpdogan, Memorial Sloan Kettering Cancer Center
  • Debabrata Banerjee, University of Medicine and Dentistry of New Jersey
  • Eunice Wang, Memorial Sloan Kettering Cancer Center
  • Malcolm A.S. Moore, Memorial Sloan Kettering Cancer Center
  • Joseph R. Bertino, University of Medicine and Dentistry of New Jersey
Disciplines
Publication Date
January 9, 2004
DOI
10.1016/j.ymthe.2004.06.115
Citation Information
Tulin Budak-Alpdogan, Onder Alpdogan, Debabrata Banerjee, Eunice Wang, et al.. "Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene" Molecular Therapy Vol. 10 Iss. 3 (2004) p. 574 - 584
Available at: http://works.bepress.com/tulin-budak-alpdogan/30/